Evaluation of the results of two different pancreatic transplant surgery techniques in the treatment of type 1 diabetic patients

Not Applicable

• Conditions: Condition 1: ????? ??? 1. Condition 2: Pancreas transplant.; Type 1 diabetes mellitus; Pancreas transplant status; Z94.83

• Registration Number: IRCT20210625051701N2
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 May 2022

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patient's consent
Pancreas transplant form (living donor or deceased donor)
Having a simultaneous pancreas-kidney (SPK) transplant
Patients with diabetic nephropathy who undergo portal venous drainage

Exclusion Criteria

Unwillingness to participate in study
Patients who undergo systemic venous drainage
Patients who undergo pancreas transplant alone (PTA)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Transplant rejection. Timepoint: Up to 28 days after surgery. Method of measurement: Clinical features and diagnostic tests.;Incidence of arterial complications. Timepoint: Up to 28 days after surgery. Method of measurement: Sonography.;Mortality. Timepoint: Up to 28 days after surgery. Method of measurement: Absence of pulse rate and flat ECG.

Secondary Outcome Measures

Name	Time	Method
Operation time. Timepoint: During operation. Method of measurement: Using the timer.;Incidence of postoperative pancreatitis. Timepoint: Up to 28 days after surgery. Method of measurement: Lab data and Sonography.;The cold ischemic phase. Timepoint: From 24 hours before surgery. Method of measurement: Using the timer.;The warm ischemic time. Timepoint: From the time the donor organ is removed from the storage ice to the start of re-perfusion after transplantation. Method of measurement: Using the timer.